Marta Zofia Krawczyk, Age 734536 N Morris Blvd, Milwaukee, WI 53211

Marta Krawczyk Phones & Addresses

4080 Glencoe Ave UNIT 302, Marina Dl Rey, CA 90292

Marina del Rey, CA

4521 Donna Ct, Milwaukee, WI 53223 (414) 362-0041

Brown Deer, WI

Sheboygan, WI

Germantown, WI

The Woodlands, TX

Marina Dl Rey, CA

4210 S Ravinia Dr APT 114, Greenfield, WI 53221

Show more

Emails

Mentions for Marta Zofia Krawczyk

Marta Krawczyk resumes & CV records

Resumes

Marta Krawczyk Photo 30

Scientist At Sigma Aldrich

Position:
Scientist at Sigma Aldrich
Location:
Greater Milwaukee Area
Industry:
Chemicals
Work:
Sigma Aldrich - Greater Milwaukee Area since Nov 2004
Scientist
Sigma Aldrich - Greater Milwaukee Area Jun 2000 - Nov 2004
Scientist
Education:
Keller Graduate School of Management of DeVry University 2004 - 2010
MS, MBA
Warsaw University of Technology
PhD, Chemistry
Marta Krawczyk Photo 31

Scientist At Sigma Aldrich

Position:
Scientist at Sigma Aldrich
Location:
Greater Milwaukee Area
Industry:
Chemicals
Work:
Sigma Aldrich
Scientist
Marta Krawczyk Photo 32

Marta Krawczyk

Publications & IP owners

Us Patents

Methods And Compositions For The Manufacture Of C-3€² And C-4€² Anthracycline Antibiotics

US Patent:
6673907, Jan 6, 2004
Filed:
Sep 19, 2001
Appl. No.:
09/956588
Inventors:
Waldemar Priebe - Houston TX
Izabella Fokt - The Woodlands TX
Teresa Przewloka - Acton MA
Marta Krawczyk - Greenfield WI
Piotr Skibicki - Warsaw, PL
Grzegorz Grynkiewicz - Lominaki, PL
Roman Perez-Soler - New York NY
Assignee:
Houston Pharmaceuticals, Inc. - Houston TX
International Classification:
C07H 100
US Classification:
536 64, 536 172, 536 173, 536 175, 536 185
Abstract:
The present invention discloses new and novel substituted anthracyclines with modified alkyl-aromatic ring substitutions on the C-3â of the sugar moiety or modified or unmodified alkyl-aromatic ring substitutions at the C-4â of the sugar moiety. It also discloses novel methods for the preparation of sugar substrates and methods for the preparation of anthracycline antibiotics. These anthracycline analogs show high cytotoxicity in vitro against several tumor cell lines.

Methods And Compositions For The Manufacture Of C-3′ And C-4′ Anthracycline Antibiotics

US Patent:
7109177, Sep 19, 2006
Filed:
Jan 6, 2004
Appl. No.:
10/752426
Inventors:
Waldeman Priebe - Houston TX, US
Izabella Fokt - The Woodlands TX, US
Teresa Przewloka - Burlington MA, US
Marta Krawczyk - Greenfield WI, US
Piotr Skibicki - Warsaw, PL
Grzegorz Grynkiewicz - Lominaki, PL
Roman Perez-Soler - New York NY, US
Assignee:
Houston Pharmaceuticals, Inc. - Houston TX
International Classification:
A61K 31/70
C07H 15/24
US Classification:
514 34, 536 64
Abstract:
The present invention discloses new and novel substituted anthracyclines with modified alkyl-aromatic ring substitutions on the C-3′ of the sugar moiety or modified or unmodified alkyl-aromatic ring substitutions at the C-4′ of the sugar moiety. It also discloses novel methods for the preparation of sugar substrates and methods for the preparation of anthracycline antibiotics. These anthracycline analogs show high cytotoxicity in vitro against several tumor cell lines.

Anthracycline Antibiotics And Methods Of Treating Cancer Using The Same

US Patent:
7557090, Jul 7, 2009
Filed:
Aug 1, 2006
Appl. No.:
11/496976
Inventors:
Waldemar Priebe - Houston TX, US
Izabella Fokt - The Woodlands TX, US
Teresa Prezewloka - Acton MA, US
Marta Krawczyk - Greenfield WI, US
Piotr Skibicki - Warsaw, PL
Grzegorz Grynkiewicz - Lominaki, PL
Roman Perez-Soler - New York NY, US
Assignee:
Houston Pharmaceuticals, Inc. - Houston TX
International Classification:
A61K 31/70
US Classification:
514 34
Abstract:
The present invention discloses new and novel substituted anthracyclines with modified alkyl-aromatic ring substitutions on the C-3′ of the sugar moiety or modified or unmodified alkyl-aromatic ring substitutions at the C-4′ of the sugar moiety. It also discloses novel methods for the preparation of sugar substrates and methods for the preparation of anthracycline antibiotics. These anthracycline analogs show high cytotoxicity in vitro against several tumor cell lines.

Methods And Compositions For The Manufacture Of Halogenated Anthracyclines With Increased Antitumor Activity, Other Anthracyclines, Halogenated Sugars, And Glycosyl Donors

US Patent:
6355784, Mar 12, 2002
Filed:
Jun 10, 1999
Appl. No.:
09/330226
Inventors:
Waldemar Priebe - Houston TX, 77005
Marta Krawczyk - Lexington KY, 40503
Piotr Skibicki - Warsaw 04015, PL
Izabela Fokt - The Woodlands TX, 77380
Krzysztof Dziewiszek - The Woodlands TX, 77380
Grzegorz Grynkiewicz - 05-092 Lomianki, PL
Roman Perez-Soler - New York NY, 10016
International Classification:
C07H 1524
US Classification:
536 64, 536 41, 536 172, 536 184, 536 187, 536122
Abstract:
The present invention discloses new and novel halogenated anthracyclines linked through the saccharide portions. These congeners show high activity in vitro against several tumor cell lines. In doxorubicin (DOX) sensitive cell lines, they are at least as cytotoxic as DOX and in some cases more so. Many of these 4â- and 6â-fluorinated anthracyclines are more effective against multidrug-resistant tumors than was DOX, and/or have greater effectiveness than DOX against DOX sensitive cells. The compounds of this invention also have anti-amyloidogenic effects and the use of these compounds in the treatment of Alzheimers disease is contemplated.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.